Drug Science, Policy and Law
Drug Science, Policy and Law aims to be the definitive source of evidence-based information and comment for academics, scientists, policymakers, frontline workers and the general public on drugs and related issues.
Drug Science, Policy and Law is the official journal of the Independent Scientific Committee on Drugs. This journal is a member of the Committee on Publication Ethics (COPE).
Submit your manuscript today at https://mc.manuscriptcentral.com/dsp
A peer-reviewed journal of science, policy and law relating to drugs, Drug Science, Policy and Law is international in scope and grounded in a rigorous evidence base making it essential reading for all those in the field and related disciplines.
In particular, the following topics are covered:
Those relating to drug science, both from hard science – addiction science, chemistry, psychopharmacology, psychiatry, psychology, forensic toxicology, behavioural neuroscience – and from social science and other related fields – criminology, law, policy.
| David J. Nutt | Imperial College London, London, United Kingdom |
| Pallab Seth | British Association for Psychopharmacology, UK |
| Anne Katrin Schlag | Imperial College London, UK |
| Valerie Curran | University College London, UK |
| Michael Farrell | University of New South Wales, Australia |
| Rudi Fortson | Queen Mary University of London, UK |
| João Goulão | SICAD, Portugal |
| Mohamad Hussain Bin Habil | University of Malaya, Malaysia |
| Wayne Hall | University of Queensland, Australia |
| Martin Jelsma | Transnational Institute, Netherlands |
| Evgeny Krupitsky | Bekhterev St. Petersburg Research Psychoneurological Institute, Russia |
| Fiona Measham | Durham University, UK |
| Charles O'Brien | University of Pennsylvania, USA |
| Rajat Ray | All India Institute of Medical Sciences, India |
| Douglas Sellman | University of Otago, New Zealand |
| Rachel Tyndale | University of Toronto, Canada |
| Wim van den Brink | Academic Medical Center, Netherlands |
- ProQuest